A nalysts at Wall Street firm Bernstein have raised their price target on Eli Lilly’s (LLY) stock to $1,300 from $1,100 and ...

Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...

Novo Nordisk's stock fell after semaglutide's Alzheimer's news. Click here for how strong fundamentals and growth catalysts ...

US stocks surged on Monday to start the shortened Thanksgiving trading week as US policymakers buoyed hopes for an ...

Seeking Alpha analysts have upgraded Nvidia (NVDA) and Alibaba (BABA), emphasizing their strategic positions in the AI and ...

Micron is benefiting from a shift toward AI-grade memory with HBM and data-center DRAM driving margin expansion and record earnings. Read my analysis of MU stock.

Eli Lilly › Just a handful of companies have entered the rarefied trillionaire club. So far, it's been limited to huge ...

US stock futures rose on Monday, eyeing a rebound to start the shortened Thanksgiving trading week buoyed by hopes for an ...

US stocks surged on Monday, heading toward a rebound to start the shortened Thanksgiving trading week as US policymakers ...

Novo Nordisk's stock tumbles after its oral GLP-1 drug failed to show a benefit over a placebo against Alzheimer's disease.

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, driven not only by outstanding earnings and a notable margin increase, but ...

Novo's trial setback tests GLP-1-heavy ETFs, highlighting concentration risks while Eli Lilly's diversified pipeline offers ...